Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03521817 · ClinicalTrials.gov registry record · NA

The Effects of Alcohol Consumption on Central Adiposity

A NA study of Obesity and Weight Loss, sponsored by Pennington Biomedical Research Center.

Completed
Registry status
NA
Development phase
12
Enrollment target
1
Study location

NCT03521817 is a NA study of Obesity and Weight Loss that has completed, run by Pennington Biomedical Research Center. The registered enrollment target is 12 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03521817, a NA study of Obesity and Weight Loss, has completed, sponsored by Pennington Biomedical Research Center.

COMPLETED
Registry status
NA
Development phase
12 participants
Enrollment target
1
Study location

Study Summary

The objective of the proposed study is to enroll women with obesity that will undergo a controlled, energy restricted feeding intervention to test the effects of chronic ethanol consumption on adipose distribution and circulating testosterone during weight loss.

Interventions

  • OTHER Alcohol
  • OTHER No Alcohol

Study Locations (1)

Louisiana

  • Pennington Biomedical Research Center - Baton Rouge

Trial Details

FieldValue
Enrollment Target 12 participants
Start Date 2018-05-18
Est. Completion 2019-11-04
Phase NA

What the Registry Record Tells You About NCT03521817

The ClinicalTrials.gov registry entry for NCT03521817 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (99% lower). The listed sponsor is Pennington Biomedical Research Center, which has 258 total studies on file at ClinicalTrials.gov.

The record links to 5 conditions, with Obesity appearing as the primary indexed condition, and to 2 interventions - of which Alcohol is the first listed.

NCT03521817 reports 1 study location spanning 1 distinct geographic area - top geographies include Louisiana.

Frequently Asked Questions

What is clinical trial NCT03521817 about?

NCT03521817 is a clinical study titled "The Effects of Alcohol Consumption on Central Adiposity". The objective of the proposed study is to enroll women with obesity that will undergo a controlled, energy restricted feeding intervention to test the effects of chronic ethanol consumption on adipose distribution and circulating testosterone during weight loss.

What is the current status of trial NCT03521817?

This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2018-05-18. Estimated completion is 2019-11-04.

What conditions does trial NCT03521817 study?

This clinical trial studies the following conditions: Obesity, Weight Loss, Alcohol Drinking, Adiposity, Visceral Obesity.

What interventions are being tested in trial NCT03521817?

The interventions under investigation include: Alcohol (OTHER), No Alcohol (OTHER).

Who is sponsoring clinical trial NCT03521817?

This trial is sponsored by Pennington Biomedical Research Center, which has 258 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03521817 being conducted?

This trial has 1 study location across Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.